SAN DIEGO and LIEGE, Belgium, March 30, 2021 /PRNewswire/ — Alvalux Medical, a Belgian medtech wearables company, and its USA subsidiary CicaLux Inc., has been awarded its first patent from the United States Patent and Trademark Office for its CicaLux® product line. The invention (U.S. Patent 10,953,238) is an award-winning, wearable dermal repair system that delivers energized combination therapy to treat skin-related conditions, diseases and disorders.
“This patent supports our first award-winning product, CicaLux Energized Scar-Care, a new scar therapy treatment at the crossroads of aesthetic care and wearable technology that is focused on helping the approximately 250 million people per year who undergo incisional surgeries,” says Michel Alvarez, CEO and inventor. “Its broad claims also cover an exciting CicaLux branded pipeline, ranging from anti-aging, stretch mark and acne treatments to photo-dynamic therapies for skin cancer, psoriasis and advanced wound care.”
This CE-marked and FDA-registered, eco-friendly wearable device marketed as CicaLux Energized Scar-Care features proprietary, non-invasive Triple Action Therapy, which combines the benefits of hydration, heat and compression therapy. It helps improve old and prevent new hypertrophic and keloid scar healing, flatten and minimize old and new scars, improve skin’s color and texture,…
